Jordan Axelrad
MD, MPH
Associate Professor; Director, Clinical and Translational Research, Inflammatory Bowel Disease Center at NYU Langone Health
NYU Grossman School of Medicine

Jordan E. Axelrad, MD, MPH, is the Director of Clinical and Translational Research in the Inflammatory Bowel Disease Center at NYU Langone Health, and an Associate Professor of Medicine in the Division of Gastroenterology, Department of Medicine, at NYU Grossman School of Medicine. Dr. Axelrad received his medical and public health degrees from Tufts University School of Medicine. He completed his internal medicine training at the Icahn School of Medicine at Mount Sinai and went on to complete fellowship training in gastroenterology at Columbia University Medical Center, serving as chief fellow. Dr. Axelrad received specialized training in clinical and translational IBD investigation, and his research in areas such as environmental factors in IBD, and in malignant and infectious complications of IBD, has been published and presented internationally. Dr. Axelrad is a member of multiple international gastrointestinal societies, is involved in IBD guideline development and educational programs, and serves on the editorial board of multiple journals. He is the principal investigator of the institutional NYU IBD biorepository, multiple clinical trials and international registries, and mentors trainees in various research activities. His current research is funded by the Crohn’s and Colitis Foundation, the Judith and Stewart Colton Center for Autoimmunity, the New York Crohn's and Colitis Organization, and the National Institutes of Health, and focuses on IBD epidemiology, triggers of IBD onset and flare, and models for predicting responsiveness to IBD therapies.

Sessions

Register
Industry Supported Session

S1P Receptor Modulators in the Management of Ulcerative Colitis: Evolving Data and Clinical Strategies

Saturday, April 06, 2024
9:00 AM - 9:30 AM

Session V: S1P Receptor Modulators in the Management of Ulcerative Colitis: Evolving Data and Clinical Strategies

Saturday, April 27, 2024
9:00 AM - 9:45 AM
General Session

Session VII: IBD Complications

Saturday, April 27, 2024
12:15 PM - 1:00 PM

Post-Operative Crohn's Disease

Saturday, April 27, 2024
12:30 PM - 12:45 PM
Industry Supported Session

S1P Receptor Modulators in the Management of Ulcerative Colitis: Evolving Data and Clinical Strategies

Saturday, June 22, 2024
9:00 AM - 9:30 AM
Industry Supported Session

Session V: S1P Receptor Modulators in the Management of Ulcerative Colitis: Evolving Data and Clinical Strategies

Saturday, June 22, 2024
9:00 AM - 9:45 AM

Session VII: IBD Complications

Saturday, June 22, 2024
12:15 PM - 1:00 PM
General Session

Session VII: IBD Complications

Saturday, June 22, 2024
12:15 PM - 1:00 PM
General Session

Post-Operative Crohn's Disease

Saturday, June 22, 2024
12:30 PM - 12:45 PM
Industry Supported Session

S1P Receptor Modulators in the Management of Ulcerative Colitis: Evolving Data and Clinical Strategies

Saturday, July 20, 2024
9:00 AM - 9:30 AM